HEADER SIGNALING PROTEIN/INHIBITOR 25-MAR-19 6OCQ TITLE CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH A PYRROLIDINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL RESIDUES 1-294; COMPND 5 SYNONYM: CELL DEATH PROTEIN RIP,RECEPTOR-INTERACTING PROTEIN 1,RIP-1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RIPK1, RIP, RIP1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA AFF. FRUGIPERDA 2 RZ-2014; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1491790 KEYWDS INHIBITOR, SIGNALING PROTEIN, SIGNALING PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.H.THORPE,P.A.HARRIS REVDAT 3 13-MAR-24 6OCQ 1 REMARK REVDAT 2 05-JUN-19 6OCQ 1 JRNL REVDAT 1 08-MAY-19 6OCQ 0 JRNL AUTH P.A.HARRIS,N.FAUCHER,N.GEORGE,P.M.EIDAM,B.W.KING,G.V.WHITE, JRNL AUTH 2 N.A.ANDERSON,D.BANDYOPADHYAY,A.M.BEAL,V.BENETON,S.B.BERGER, JRNL AUTH 3 N.CAMPOBASSO,S.CAMPOS,C.A.CAPRIOTTI,J.A.COX,A.DAUGAN, JRNL AUTH 4 F.DONCHE,M.H.FOUCHET,J.N.FINGER,B.GEDDES,P.J.GOUGH, JRNL AUTH 5 P.GRONDIN,B.L.HOFFMAN,S.J.HOFFMAN,S.E.HUTCHINSON,J.U.JEONG, JRNL AUTH 6 E.JIGOREL,P.LAMOUREUX,L.K.LEISTER,J.D.LICH,M.K.MAHAJAN, JRNL AUTH 7 J.MESLAMANI,J.E.MOSLEY,R.NAGILLA,P.M.NASSAU,S.L.NG, JRNL AUTH 8 M.T.OUELLETTE,K.K.PASIKANTI,F.POTVAIN,M.A.REILLY,E.J.RIVERA, JRNL AUTH 9 S.SAUTET,M.C.SCHAEFFER,C.A.SEHON,H.SUN,J.H.THORPE, JRNL AUTH10 R.D.TOTORITIS,P.WARD,N.WELLAWAY,D.D.WISNOSKI,J.M.WOOLVEN, JRNL AUTH11 J.BERTIN,R.W.MARQUIS JRNL TITL DISCOVERY AND LEAD-OPTIMIZATION OF 4,5-DIHYDROPYRAZOLES AS JRNL TITL 2 MONO-KINASE SELECTIVE, ORALLY BIOAVAILABLE AND EFFICACIOUS JRNL TITL 3 INHIBITORS OF RECEPTOR INTERACTING PROTEIN 1 (RIP1) KINASE. JRNL REF J.MED.CHEM. V. 62 5096 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31013427 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00318 REMARK 2 REMARK 2 RESOLUTION. 2.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 76.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 14754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.620 REMARK 3 FREE R VALUE TEST SET COUNT : 682 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 76.2118 - 4.7753 0.98 2937 141 0.1901 0.2343 REMARK 3 2 4.7753 - 3.7903 0.99 2828 134 0.1831 0.2295 REMARK 3 3 3.7903 - 3.3112 1.00 2788 135 0.2098 0.3136 REMARK 3 4 3.3112 - 3.0085 1.00 2783 141 0.2482 0.3532 REMARK 3 5 3.0085 - 2.7928 1.00 2736 131 0.2703 0.3866 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.790 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 70.52 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4315 REMARK 3 ANGLE : 1.211 5843 REMARK 3 CHIRALITY : 0.059 654 REMARK 3 PLANARITY : 0.006 747 REMARK 3 DIHEDRAL : 4.668 3615 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OCQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1000240467. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14805 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.790 REMARK 200 RESOLUTION RANGE LOW (A) : 95.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.53400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24 % PEG 4000, 0.1 M AMMONIUM ACETATE, REMARK 280 0.1 M HEPES PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.64850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.62000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.55850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.62000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.64850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.55850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -8 REMARK 465 ASP A -7 REMARK 465 TYR A -6 REMARK 465 LYS A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 LYS A 0 REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 PRO A 3 REMARK 465 ASP A 4 REMARK 465 MET A 5 REMARK 465 SER A 6 REMARK 465 LEU A 7 REMARK 465 LEU A 23 REMARK 465 ASP A 24 REMARK 465 SER A 25 REMARK 465 GLY A 26 REMARK 465 GLY A 27 REMARK 465 PHE A 28 REMARK 465 ASN A 170 REMARK 465 GLU A 171 REMARK 465 GLU A 172 REMARK 465 HIS A 173 REMARK 465 ASN A 174 REMARK 465 GLU A 175 REMARK 465 LEU A 176 REMARK 465 ARG A 177 REMARK 465 GLU A 178 REMARK 465 VAL A 179 REMARK 465 ASP A 180 REMARK 465 GLY A 181 REMARK 465 THR A 182 REMARK 465 ALA A 183 REMARK 465 LYS A 184 REMARK 465 LYS A 185 REMARK 465 ASN A 186 REMARK 465 GLY A 187 REMARK 465 GLY A 188 REMARK 465 MET B -8 REMARK 465 ASP B -7 REMARK 465 TYR B -6 REMARK 465 LYS B -5 REMARK 465 ASP B -4 REMARK 465 ASP B -3 REMARK 465 ASP B -2 REMARK 465 ASP B -1 REMARK 465 LYS B 0 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 PRO B 3 REMARK 465 ASP B 4 REMARK 465 MET B 5 REMARK 465 SER B 6 REMARK 465 PHE B 28 REMARK 465 GLY B 29 REMARK 465 ARG B 177 REMARK 465 GLU B 178 REMARK 465 VAL B 179 REMARK 465 ASP B 180 REMARK 465 GLY B 181 REMARK 465 THR B 182 REMARK 465 ALA B 183 REMARK 465 LYS B 184 REMARK 465 LYS B 185 REMARK 465 ASN B 186 REMARK 465 GLY B 187 REMARK 465 GLY B 188 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 11 CD CE NZ REMARK 470 GLU A 19 CG CD OE1 OE2 REMARK 470 GLU A 22 CG CD OE1 OE2 REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 LYS A 49 CD CE NZ REMARK 470 ASN A 52 OD1 ND2 REMARK 470 GLU A 55 CG CD OE1 OE2 REMARK 470 HIS A 56 ND1 CD2 CE1 NE2 REMARK 470 LYS A 65 CD CE NZ REMARK 470 GLU A 85 CD OE1 OE2 REMARK 470 LYS A 87 CD CE NZ REMARK 470 GLU A 107 CG CD OE1 OE2 REMARK 470 MET A 108 CG SD CE REMARK 470 LYS A 163 CD CE NZ REMARK 470 LYS A 167 CG CD CE NZ REMARK 470 GLU A 229 CG CD OE1 OE2 REMARK 470 ILE A 232 CG1 CG2 CD1 REMARK 470 LEU B 7 CG CD1 CD2 REMARK 470 LYS B 11 CD CE NZ REMARK 470 LYS B 13 CE NZ REMARK 470 GLU B 19 CD OE1 OE2 REMARK 470 LYS B 30 CG CD CE NZ REMARK 470 LYS B 49 CD CE NZ REMARK 470 ILE B 54 CG1 CG2 CD1 REMARK 470 GLU B 55 CD OE1 OE2 REMARK 470 HIS B 56 ND1 CD2 CE1 NE2 REMARK 470 LYS B 87 CD CE NZ REMARK 470 TYR B 88 CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 107 CG CD OE1 OE2 REMARK 470 MET B 108 CG SD CE REMARK 470 LYS B 163 CD CE NZ REMARK 470 MET B 164 SD CE REMARK 470 LYS B 167 CD CE NZ REMARK 470 GLU B 171 CD OE1 OE2 REMARK 470 GLU B 172 CG CD OE1 OE2 REMARK 470 HIS B 173 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 204 CG CD CE NZ REMARK 470 LYS B 242 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 41 CA - CB - CG ANGL. DEV. = 14.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 20 156.89 177.57 REMARK 500 ILE A 54 2.58 -62.53 REMARK 500 LYS A 137 -14.54 74.31 REMARK 500 ASP A 138 43.94 -143.74 REMARK 500 ASN A 199 22.28 48.93 REMARK 500 SER B 20 116.93 -161.17 REMARK 500 HIS B 72 147.66 -171.59 REMARK 500 LYS B 137 -4.84 73.55 REMARK 500 ASP B 138 37.12 -141.92 REMARK 500 PHE B 150 27.15 48.34 REMARK 500 ASN B 199 18.56 81.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU B 7 ASN B 8 148.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M5J A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M5J B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6R5F RELATED DB: PDB REMARK 900 6R5F CONTAINS THE SAME PROTEIN BUT COMPLEXED WITH A DIFFERENT REMARK 900 INHIBITOR DBREF 6OCQ A 1 294 UNP Q13546 RIPK1_HUMAN 1 294 DBREF 6OCQ B 1 294 UNP Q13546 RIPK1_HUMAN 1 294 SEQADV 6OCQ MET A -8 UNP Q13546 INITIATING METHIONINE SEQADV 6OCQ ASP A -7 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ TYR A -6 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ LYS A -5 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP A -4 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP A -3 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP A -2 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP A -1 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ LYS A 0 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ALA A 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 6OCQ ALA A 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 6OCQ ALA A 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 6OCQ ALA A 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQADV 6OCQ MET B -8 UNP Q13546 INITIATING METHIONINE SEQADV 6OCQ ASP B -7 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ TYR B -6 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ LYS B -5 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP B -4 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP B -3 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP B -2 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ASP B -1 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ LYS B 0 UNP Q13546 EXPRESSION TAG SEQADV 6OCQ ALA B 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 6OCQ ALA B 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 6OCQ ALA B 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 6OCQ ALA B 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQRES 1 A 303 MET ASP TYR LYS ASP ASP ASP ASP LYS MET GLN PRO ASP SEQRES 2 A 303 MET SER LEU ASN VAL ILE LYS MET LYS SER SER ASP PHE SEQRES 3 A 303 LEU GLU SER ALA GLU LEU ASP SER GLY GLY PHE GLY LYS SEQRES 4 A 303 VAL SER LEU ALA PHE HIS ARG THR GLN GLY LEU MET ILE SEQRES 5 A 303 MET LYS THR VAL TYR LYS GLY PRO ASN CYS ILE GLU HIS SEQRES 6 A 303 ASN GLU ALA LEU LEU GLU GLU ALA LYS MET MET ASN ARG SEQRES 7 A 303 LEU ARG HIS SER ARG VAL VAL LYS LEU LEU GLY VAL ILE SEQRES 8 A 303 ILE GLU GLU GLY LYS TYR SER LEU VAL MET GLU TYR MET SEQRES 9 A 303 GLU LYS GLY ASN LEU MET HIS VAL LEU LYS ALA GLU MET SEQRES 10 A 303 SER THR PRO LEU SER VAL LYS GLY ARG ILE ILE LEU GLU SEQRES 11 A 303 ILE ILE GLU GLY MET ALA TYR LEU HIS GLY LYS GLY VAL SEQRES 12 A 303 ILE HIS LYS ASP LEU LYS PRO GLU ASN ILE LEU VAL ASP SEQRES 13 A 303 ASN ASP PHE HIS ILE LYS ILE ALA ASP LEU GLY LEU ALA SEQRES 14 A 303 SER PHE LYS MET TRP SER LYS LEU ASN ASN GLU GLU HIS SEQRES 15 A 303 ASN GLU LEU ARG GLU VAL ASP GLY THR ALA LYS LYS ASN SEQRES 16 A 303 GLY GLY THR LEU TYR TYR MET ALA PRO GLU HIS LEU ASN SEQRES 17 A 303 ASP VAL ASN ALA LYS PRO THR GLU LYS SER ASP VAL TYR SEQRES 18 A 303 SER PHE ALA VAL VAL LEU TRP ALA ILE PHE ALA ASN LYS SEQRES 19 A 303 GLU PRO TYR GLU ASN ALA ILE ALA GLU GLN GLN LEU ILE SEQRES 20 A 303 MET ALA ILE LYS SER GLY ASN ARG PRO ASP VAL ASP ASP SEQRES 21 A 303 ILE THR GLU TYR CYS PRO ARG GLU ILE ILE SER LEU MET SEQRES 22 A 303 LYS LEU CYS TRP GLU ALA ASN PRO GLU ALA ARG PRO THR SEQRES 23 A 303 PHE PRO GLY ILE GLU GLU LYS PHE ARG PRO PHE TYR LEU SEQRES 24 A 303 SER GLN LEU GLU SEQRES 1 B 303 MET ASP TYR LYS ASP ASP ASP ASP LYS MET GLN PRO ASP SEQRES 2 B 303 MET SER LEU ASN VAL ILE LYS MET LYS SER SER ASP PHE SEQRES 3 B 303 LEU GLU SER ALA GLU LEU ASP SER GLY GLY PHE GLY LYS SEQRES 4 B 303 VAL SER LEU ALA PHE HIS ARG THR GLN GLY LEU MET ILE SEQRES 5 B 303 MET LYS THR VAL TYR LYS GLY PRO ASN CYS ILE GLU HIS SEQRES 6 B 303 ASN GLU ALA LEU LEU GLU GLU ALA LYS MET MET ASN ARG SEQRES 7 B 303 LEU ARG HIS SER ARG VAL VAL LYS LEU LEU GLY VAL ILE SEQRES 8 B 303 ILE GLU GLU GLY LYS TYR SER LEU VAL MET GLU TYR MET SEQRES 9 B 303 GLU LYS GLY ASN LEU MET HIS VAL LEU LYS ALA GLU MET SEQRES 10 B 303 SER THR PRO LEU SER VAL LYS GLY ARG ILE ILE LEU GLU SEQRES 11 B 303 ILE ILE GLU GLY MET ALA TYR LEU HIS GLY LYS GLY VAL SEQRES 12 B 303 ILE HIS LYS ASP LEU LYS PRO GLU ASN ILE LEU VAL ASP SEQRES 13 B 303 ASN ASP PHE HIS ILE LYS ILE ALA ASP LEU GLY LEU ALA SEQRES 14 B 303 SER PHE LYS MET TRP SER LYS LEU ASN ASN GLU GLU HIS SEQRES 15 B 303 ASN GLU LEU ARG GLU VAL ASP GLY THR ALA LYS LYS ASN SEQRES 16 B 303 GLY GLY THR LEU TYR TYR MET ALA PRO GLU HIS LEU ASN SEQRES 17 B 303 ASP VAL ASN ALA LYS PRO THR GLU LYS SER ASP VAL TYR SEQRES 18 B 303 SER PHE ALA VAL VAL LEU TRP ALA ILE PHE ALA ASN LYS SEQRES 19 B 303 GLU PRO TYR GLU ASN ALA ILE ALA GLU GLN GLN LEU ILE SEQRES 20 B 303 MET ALA ILE LYS SER GLY ASN ARG PRO ASP VAL ASP ASP SEQRES 21 B 303 ILE THR GLU TYR CYS PRO ARG GLU ILE ILE SER LEU MET SEQRES 22 B 303 LYS LEU CYS TRP GLU ALA ASN PRO GLU ALA ARG PRO THR SEQRES 23 B 303 PHE PRO GLY ILE GLU GLU LYS PHE ARG PRO PHE TYR LEU SEQRES 24 B 303 SER GLN LEU GLU HET M5J A 301 18 HET SO4 A 302 5 HET M5J B 301 18 HET SO4 B 302 5 HETNAM M5J 1-[(2S)-2-(3-FLUOROPHENYL)PYRROLIDIN-1-YL]-2,2- HETNAM 2 M5J DIMETHYLPROPAN-1-ONE HETNAM SO4 SULFATE ION FORMUL 3 M5J 2(C15 H20 F N O) FORMUL 4 SO4 2(O4 S 2-) FORMUL 7 HOH *4(H2 O) HELIX 1 AA1 LYS A 13 SER A 15 5 3 HELIX 2 AA2 HIS A 56 ARG A 69 1 14 HELIX 3 AA3 LEU A 100 ALA A 106 1 7 HELIX 4 AA4 PRO A 111 LYS A 132 1 22 HELIX 5 AA5 LYS A 140 GLU A 142 5 3 HELIX 6 AA6 PHE A 162 ASN A 169 1 8 HELIX 7 AA7 THR A 189 MET A 193 5 5 HELIX 8 AA8 ALA A 194 LEU A 198 5 5 HELIX 9 AA9 THR A 206 ASN A 224 1 19 HELIX 10 AB1 ALA A 233 SER A 243 1 11 HELIX 11 AB2 PRO A 257 TRP A 268 1 12 HELIX 12 AB3 ASN A 271 ARG A 275 5 5 HELIX 13 AB4 THR A 277 LEU A 293 1 17 HELIX 14 AB5 LYS B 13 SER B 15 5 3 HELIX 15 AB6 HIS B 56 ARG B 69 1 14 HELIX 16 AB7 ASN B 99 LYS B 105 1 7 HELIX 17 AB8 PRO B 111 LYS B 132 1 22 HELIX 18 AB9 LYS B 140 GLU B 142 5 3 HELIX 19 AC1 PHE B 162 ASN B 169 1 8 HELIX 20 AC2 THR B 189 MET B 193 5 5 HELIX 21 AC3 ALA B 194 LEU B 198 5 5 HELIX 22 AC4 THR B 206 ASN B 224 1 19 HELIX 23 AC5 ALA B 233 SER B 243 1 11 HELIX 24 AC6 PRO B 257 TRP B 268 1 12 HELIX 25 AC7 ASN B 271 ARG B 275 5 5 HELIX 26 AC8 THR B 277 LEU B 293 1 17 SHEET 1 AA1 5 PHE A 17 LEU A 18 0 SHEET 2 AA1 5 LYS A 30 HIS A 36 -1 O PHE A 35 N LEU A 18 SHEET 3 AA1 5 GLY A 40 LYS A 49 -1 O GLY A 40 N HIS A 36 SHEET 4 AA1 5 LYS A 87 GLU A 93 -1 O LEU A 90 N LYS A 45 SHEET 5 AA1 5 LEU A 78 GLU A 84 -1 N ILE A 82 O SER A 89 SHEET 1 AA2 3 GLY A 98 ASN A 99 0 SHEET 2 AA2 3 ILE A 144 VAL A 146 -1 O VAL A 146 N GLY A 98 SHEET 3 AA2 3 ILE A 152 ILE A 154 -1 O LYS A 153 N LEU A 145 SHEET 1 AA3 5 PHE B 17 GLU B 22 0 SHEET 2 AA3 5 VAL B 31 HIS B 36 -1 O PHE B 35 N LEU B 18 SHEET 3 AA3 5 GLY B 40 LYS B 49 -1 O MET B 44 N SER B 32 SHEET 4 AA3 5 LYS B 87 MET B 92 -1 O MET B 92 N ILE B 43 SHEET 5 AA3 5 LEU B 78 GLU B 84 -1 N ILE B 82 O SER B 89 SHEET 1 AA4 2 ILE B 144 VAL B 146 0 SHEET 2 AA4 2 ILE B 152 ILE B 154 -1 O LYS B 153 N LEU B 145 SITE 1 AC1 10 MET A 67 VAL A 76 MET A 92 LEU A 129 SITE 2 AC1 10 VAL A 134 HIS A 136 ILE A 154 ALA A 155 SITE 3 AC1 10 ASP A 156 SER A 161 SITE 1 AC2 4 ILE A 252 GLU A 254 TYR A 255 CYS A 256 SITE 1 AC3 8 MET B 67 LEU B 70 VAL B 76 LEU B 78 SITE 2 AC3 8 ILE B 154 ALA B 155 ASP B 156 PHE B 162 SITE 1 AC4 4 VAL B 249 ILE B 252 GLU B 254 CYS B 256 CRYST1 47.297 95.117 127.240 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021143 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010513 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007859 0.00000